RANK and RANKL were expressed by the tumour cells and the authors observed complete metabolic remission for over 18 months strengthening the potential therapeutic value of blocking RANK/RANKL signalling in osteosarcoma [93]. The gene discussed is TNFSF11; the disease is osteosarcoma.